References
- Todoroff R J, Brodey R S. Oral and pharyngeal neoplasia in the dog. A retrospective survey of 361 cases. J Am Vet Med Assoc 1979; 175: 567–571
- Bostock D E. Prognosis after surgical excision of canine melanomas. Vet Pathol 1979; 16: 32–40
- Harvey H J, MacEwen E G, Braun D, et al. Prognostic criteria for dogs with oral melanoma. J Am Vet Med Assoc 1981; 178: 580–582
- Theilen G H, Madewell B R. Tumors of the digestive tract. Veterinary Cancer Medicine, G H Theilen, B R Madewell. Lea & Febiger, Philadelphia 1979; 307–315
- Morton D L, Elber F R, Wisenburger T H, . Multimodality therapy of malignant melanoma, skeletal and soft tissue sarcoma using immunotherapy, chemotherapy and radiation. Adjuvant Therapy of Cancer, S E Salmon, III, et al. Grune & Stratton, Jones, New York 1981; 241–251
- Lipton A, Harvey H A, Lawrence B, et al. Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma. Cancer 1983; 51: 57–60
- Balch C M, Smalley R V, Bartolucci A A, et al. A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (stage I). Cancer 1982; 49: 1079–1084
- Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
- Dixon W J. BMDP Statistical Software. University of California Press, Los Angeles 1981; 557–585
- Christie G H, Bomford R. Mechanisms of macrophage activation by Corynebacterium parvum. I. In vitro experiments. Cell Immunol 1975; 17: 141–149
- Bomford R, Christie G H. Mechanisms of macrophage activation by Corynebacterium parvum. II. In vivo experiments. Cell Immunol 1975; 17: 150–155
- Wolmark N, Fisher B. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor bearing mice. Cancer Res 1974; 34: 2869–2872
- Sljivic V S, Watson S R. The adjuvant effect of C. parvum: T-cell dependence of macrophage activation. J Exp Med 1977; 145: 45–57
- Halpern B. Corynebacterium parvum: Applications in Experimental and Clinical Oncology. Plenum Press, New York 1975
- Scott M T. Corynebacterium parvum as an immunotherapeutic anticancer agent. Semin Oncol 1974; 1: 367–378
- Hila E Y, Pinsky C M, Hirshaut Y, et al. Surgical adjuvant therapy of malignant melanoma with Corynebacterium parvum. Cancer 1981; 481: 245–251
- Terry W D. Immunotherapy of malignant melanoma. N Engl Med 1980; 303: 1179–1185
- Murray J L, Ishmael R D, Bottomley R H, et al. Inefficacy of Sc Corynebacterium parvum in Stage I malignant melanoma: Preliminary results of a single-institutional pilot study. Cancer Treat Rep 1983; 67: 191–192